PDGF-B/PDGFR-β Signaling: A New Potential Therapeutic Target of Atrial Fibrillation?

Publisher： Karger

E-ISSN： 1421-9751|134|1|19-21

ISSN： 0008-6312

Source： Cardiology, Vol.134, Iss.1, 2016-01, pp. : 19-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

HBV promotes the proliferation of hepatic stellate cells via the PDGF-B/PDGFR-β signaling pathway in vitro

By                

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-01 ,pp. : 1443-1450

Spandidos Publications

Access to resources Recommend Favorite

The Role of Platelet-Derived Growth Factor-B/Platelet-Derived Growth Factor Receptor-β Signaling in Chronic Atrial Fibrillation

By  

Cardiology, Vol. 133, Iss. 4, 2016-01 ,pp. : 242-256

Karger

Access to resources Recommend Favorite

Transglutaminase 2 Promotes PDGF-Mediated Activation of PDGFR/Akt1 and β-Catenin Signaling in Vascular Smooth Muscle Cells and Supports Neointima Formation

By  

Journal of Vascular Research, Vol. 51, Iss. 6, 2015-01 ,pp. : 418-428

Karger

Access to resources Recommend Favorite

The Inflammatory Hypothesis of Atrial Fibrillation: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 6, 2015-06 ,pp. : 641-643

John Wiley & Sons Inc

Access to resources Recommend Favorite

A key role for Rac and Pak signaling in neutrophil extracellular traps (NETs) formation defines a new potential therapeutic target

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 269-276

John Wiley & Sons Inc

Access to resources Recommend Favorite